Rodríguez-Arévalo S - Search Results

1

Pharmacology and preclinical validation of a novel anticancer compound targeting PEPCK-M.

Aragó M, Moreno-Felici J, Abás S, Rodríguez-Arévalo S, Hyroššová P, Figueras A, Viñals F, Pérez B, Loza MI, Brea J, Latorre P, Carrodeguas JA, García-Rovés PM, Galdeano C, Ginex T, Luque FJ, Escolano C, Perales JC. Aragó M, et al. Biomed Pharmacother. 2020 Jan;121:109601. doi: 10.1016/j.biopha.2019.109601. Epub 2019 Nov 15. Biomed Pharmacother. 2020. PMID: 31739159 Free article.

2

Neuroprotective Effects of a Structurally New Family of High Affinity Imidazoline I₂ Receptor Ligands.

Abás S, Erdozain AM, Keller B, Rodríguez-Arévalo S, Callado LF, García-Sevilla JA, Escolano C. Abás S, et al. ACS Chem Neurosci. 2017 Apr 19;8(4):737-742. doi: 10.1021/acschemneuro.6b00426. Epub 2017 Jan 4. ACS Chem Neurosci. 2017. PMID: 28029766

3

Behavioral and Cognitive Improvement Induced by Novel Imidazoline I₂ Receptor Ligands in Female SAMP8 Mice.

Griñán-Ferré C, Vasilopoulou F, Abás S, Rodríguez-Arévalo S, Bagán A, Sureda FX, Pérez B, Callado LF, García-Sevilla JA, García-Fuster MJ, Escolano C, Pallàs M. Griñán-Ferré C, et al. Neurotherapeutics. 2019 Apr;16(2):416-431. doi: 10.1007/s13311-018-00681-5. Neurotherapeutics. 2019. PMID: 30460457 Free PMC article.

4

Phosphoenolpyruvate from Glycolysis and PEPCK Regulate Cancer Cell Fate by Altering Cytosolic Ca².

Moreno-Felici J, Hyroššová P, Aragó M, Rodríguez-Arévalo S, García-Rovés PM, Escolano C, Perales JC. Moreno-Felici J, et al. Among authors: rodriguez arevalo s. Cells. 2019 Dec 19;9(1):18. doi: 10.3390/cells9010018. Cells. 2019. PMID: 31861674 Free PMC article.

5

Bicyclic α-Iminophosphonates as High Affinity Imidazoline I₂ Receptor Ligands for Alzheimer's Disease.

Abás S, Rodríguez-Arévalo S, Bagán A, Griñán-Ferré C, Vasilopoulou F, Brocos-Mosquera I, Muguruza C, Pérez B, Molins E, Luque FJ, Pérez-Lozano P, de Jonghe S, Daelemans D, Naesens L, Brea J, Loza MI, Hernández-Hernández E, García-Sevilla JA, García-Fuster MJ, Radan M, Djikic T, Nikolic K, Pallàs M, Callado LF, Escolano C. Abás S, et al. Among authors: rodriguez arevalo s. J Med Chem. 2020 Apr 9;63(7):3610-3633. doi: 10.1021/acs.jmedchem.9b02080. Epub 2020 Mar 19. J Med Chem. 2020. PMID: 32150414

6

Amelioration of BPSD-Like Phenotype and Cognitive Decline in SAMP8 Mice Model Accompanied by Molecular Changes after Treatment with I₂-Imidazoline Receptor Ligand MCR5.

Vasilopoulou F, Bagan A, Rodriguez-Arevalo S, Escolano C, Griñán-Ferré C, Pallàs M. Vasilopoulou F, et al. Among authors: rodriguez arevalo s. Pharmaceutics. 2020 May 23;12(5):475. doi: 10.3390/pharmaceutics12050475. Pharmaceutics. 2020. PMID: 32456135 Free PMC article.

7

Correction to Bicyclic α-Iminophosphonates as High Affinity Imidazoline I₂ Receptor Ligands for Alzheimer's Disease.

Abás S, Rodríguez-Arévalo S, Bagán A, Griñán-Ferré C, Vasilopoulou F, Brocos-Mosquera I, Muguruza C, Pérez B, Molins E, Luque FJ, Pérez-Lozano P, de Jonghe S, Daelemans D, Naesens L, Brea J, Loza MI, Hernández-Hernández E, García-Sevilla JA, García-Fuster MJ, Radan M, Djikic T, Nikolic K, Pallàs M, Callado LF, Escolano C. Abás S, et al. Among authors: rodriguez arevalo s. J Med Chem. 2020 Sep 24;63(18):10529. doi: 10.1021/acs.jmedchem.0c01324. Epub 2020 Sep 14. J Med Chem. 2020. PMID: 32924503 No abstract available.

8

I₂ imidazoline receptor modulation protects aged SAMP8 mice against cognitive decline by suppressing the calcineurin pathway.

Vasilopoulou F, Griñán-Ferré C, Rodríguez-Arévalo S, Bagán A, Abás S, Escolano C, Pallàs M. Vasilopoulou F, et al. Among authors: rodriguez arevalo s. Geroscience. 2021 Apr;43(2):965-983. doi: 10.1007/s11357-020-00281-2. Epub 2020 Oct 31. Geroscience. 2021. PMID: 33128688 Free PMC article.

9

Synthesis, Characterization and HPLC Analysis of the (1S,2S,5R)-Diastereomer and the Enantiomer of the Clinical Candidate AR-15512.

Rodríguez-Arévalo S, Pujol E, Abás S, Galdeano C, Escolano C, Vázquez S. Rodríguez-Arévalo S, et al. Molecules. 2021 Feb 9;26(4):906. doi: 10.3390/molecules26040906. Molecules. 2021. PMID: 33572112 Free PMC article.

10

Disease-modifying treatment with I₂ imidazoline receptor ligand LSL60101 in an Alzheimer's disease mouse model: a comparative study with donepezil.

Vasilopoulou F, Rodríguez-Arévalo S, Bagán A, Escolano C, Griñán-Ferré C, Pallàs M. Vasilopoulou F, et al. Among authors: rodriguez arevalo s. Br J Pharmacol. 2021 Aug;178(15):3017-3033. doi: 10.1111/bph.15478. Epub 2021 May 24. Br J Pharmacol. 2021. PMID: 33817786 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13 results

Search Page

Filters